Jonathan H Schatz

Medicine

Phone(520) 626-2272
Emailschatzj@email.arizona.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Jonathan H Schatz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Finished
1 Not started

Developing a novel platform for rapid identification of drug targets and anti-targets
Schatz, J. H.
Project: Research project
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose
Schatz, J. H.
National Institutes of Health
9/19/14 → 8/31/19
Project: Research project

1449 Citations
14 h-Index
22 Article
3 Review article
2 Comment/debate
2 Editorial
More
- 2 Letter

The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma
Rajan, S. S., Amin, A. D., Li, L., Rolland, D. C., Li, H., Kwon, D., Kweh, M. F., Arumov, A., Roberts, E. R., Yan, A., Basrur, V., Elenitoba-Johnson, K. S. J., Chen, X. S., Puvvada, S. D., Lussier, Y. A., Bilbao, D., Lim, M. S. & Schatz, J. H., Mar 5 2020, In: Oncogene. 39, 10, p. 2103-2117 15 p.
Research output: Contribution to journal › Article › peer-review
Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive Patients
Byrnes, D. M., Vargas, F., Dermarkarian, C., Kahn, R., Kwon, D., Hurley, J., Schatz, J. H. & Masetti, R., 2019, In: Journal of Oncology. 2019, 4047617.
Research output: Contribution to journal › Article › peer-review

Open Access
12 Scopus citations
CRISPR genome editing of murine hematopoietic stem cells to create Npm1-Alk causes ALK¹ lymphoma after transplantation
Rajan, S. S., Li, L., Kweh, M. F., Kunkalla, K., Amin, A. D., Agarwal, N. K., Vega, F. & Schatz, J. H., 2019, In: Blood Advances. 3, 12, p. 1788-1794 7 p.
Research output: Contribution to journal › Review article › peer-review

Open Access

1 Scopus citations
Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation
Alderuccio, J. P., Zhao, W., Desai, A., Ramdial, J., Gallastegui, N., Kimble, E., de la Fuente, M. I., Husnain, M., Rosenblatt, J. D., Alencar, A. J., Schatz, J. H., Moskowitz, C. H., Chapman, J. R., Vega, F., Reis, I. M. & Lossos, I. S., May 2019, In: American Journal of Hematology. 94, 5, p. 585-596 12 p.
Research output: Contribution to journal › Article › peer-review
5 Scopus citations
T cell–activating bispecific antibodies in cancer therapy
Trabolsi, A., Arumov, A. & Schatz, J. H., Aug 1 2019, In: Journal of Immunology. 203, 3, p. 585-592 8 p.
Research output: Contribution to journal › Article › peer-review
18 Scopus citations

Developing a novel platform for rapid identification of drug targets and anti-targets

A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose

The mechanism of cancer drug addiction in ALK-positive T-Cell lymphoma

Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive Patients

CRISPR genome editing of murine hematopoietic stem cells to create Npm1-Alk causes ALK1 lymphoma after transplantation

Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation

T cell–activating bispecific antibodies in cancer therapy

CRISPR genome editing of murine hematopoietic stem cells to create Npm1-Alk causes ALK¹ lymphoma after transplantation